Comparative Effects of Focused and Radial Shock-Wave Therapies in Hip Osteoarthritis.

NCT ID: NCT05224674

Last Updated: 2022-11-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-01-01

Study Completion Date

2022-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

There is no scientific study in the literature regarding the use of shock wave therapy in hip osteoarthritis. In this study, we aim to investigate both the effectiveness of ESWT and which type of ESWT can be more effective in hip osteoarthritis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hip Osteoarthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Large-Focused Extracorporeal Shock Wave Therapy

Group Type ACTIVE_COMPARATOR

Extracorporeal Shock Wave Therapy (ESWT)

Intervention Type DEVICE

The ESWT device is product of Elettronica Pagani, Italy.

Controlled-Unfocused Extracorporeal Shock Wave Therapy

Group Type ACTIVE_COMPARATOR

Extracorporeal Shock Wave Therapy (ESWT)

Intervention Type DEVICE

The ESWT device is product of Elettronica Pagani, Italy.

Sham Extracorporeal Shock Wave Therapy

Group Type SHAM_COMPARATOR

Extracorporeal Shock Wave Therapy (ESWT)

Intervention Type DEVICE

The ESWT device is product of Elettronica Pagani, Italy.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Extracorporeal Shock Wave Therapy (ESWT)

The ESWT device is product of Elettronica Pagani, Italy.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* unilateral or bilateral hip osteoarthritis

Exclusion Criteria

* other disorders that are contraindications for shockwave therapy, not have received ESWT treatment before
Minimum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Yuzuncu Yıl University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Volkan Şah

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Volkan Şah

Role: PRINCIPAL_INVESTIGATOR

Yüzüncü Yıl Üniversitesi Tıp Fakültesi

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Volkan Şah

Van, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Van Yuzuncu Yil University

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.